{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigaugw2ub7hjhzm4zvju2qyjnz4qfmblcvvjatdb5dyxycyphcv7i",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mkr257m3hjo2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiaixelxosg7l2t56a6z4ejhx3uo47iywmqps4igzm6m7jiiju7cri"
    },
    "mimeType": "image/jpeg",
    "size": 56650
  },
  "path": "/news/2026-04-glp-drugs-term-benefit-heart.html",
  "publishedAt": "2026-04-30T20:00:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "New research has shown that GLP‑1 weight-loss drugs deliver protection against heart attacks, strokes, and premature death over a sustained period of time. Researchers from Anglia Ruskin University (ARU) analyzed data from more than 90,000 patients enrolled in large-scale international studies and found that people given glucagon-like peptide‑1 (GLP‑1) receptor agonists were significantly less likely to suffer major cardiovascular events than those given a placebo.",
  "title": "GLP-1 drugs have long-term benefit for heart health, review suggests"
}